Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Intangibles (2018 - 2022)

Summit Therapeutics (SMMT) has disclosed Intangibles for 2 consecutive years, with $10.4 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Intangibles changed N/A year-over-year to $10.4 million, compared with a TTM value of $10.4 million through Dec 2021, changed N/A, and an annual FY2021 reading of $10.4 million, changed N/A over the prior year.
  • Intangibles was $10.4 million for Q4 2021 at Summit Therapeutics, down from $10.6 million in the prior quarter.
  • Across five years, Intangibles topped out at $13.1 million in Q4 2019 and bottomed at $10.4 million in Q4 2021.